BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 23969113)

  • 1. A prospective, randomized, controlled trial of the efficacy and safety of fibrin pad as an adjunct to control soft tissue bleeding during abdominal, retroperitoneal, pelvic, and thoracic surgery.
    Fischer CP; Bochicchio G; Shen J; Patel B; Batiller J; Hart JC
    J Am Coll Surg; 2013 Sep; 217(3):385-93. PubMed ID: 23969113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of aprotinin-free fibrin sealant versus absorbable hemostat.
    Fischer CP; Wood CG; Shen J; Batiller J; Hart JC; Patel B; Albala DM
    Clin Appl Thromb Hemost; 2011; 17(6):572-7. PubMed ID: 21873356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Hemostatic Effectiveness of the Fibrin Pad for Severe Soft-Tissue Bleeding During Abdominal, Retroperitoneal, Pelvic, and Thoracic (Non-cardiac) Surgery: A Randomized, Controlled, Superiority Trial.
    Koea J; Baldwin P; Shen J; Patel B; Batiller J; Arnaud A; Hart J; Hammond J; Fischer C; James Garden O
    World J Surg; 2015 Nov; 39(11):2663-9. PubMed ID: 26041587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective, Single-Blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols as an Adjunct to Hemostasis During Soft Tissue Open Surgery.
    Lakshman S; Aqua K; Stefanovic A; Djurdjevic S; Nyirády P; Osváth P; Davis R; Bullock A; Chen J; Ibañez J; Barrera G; Navarro-Puerto J;
    J Invest Surg; 2020 Mar; 33(3):218-230. PubMed ID: 30303427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of fibrin sealant as a hemostatic agent in expanded polytetrafluoroethylene graft placement surgery.
    Saha SP; Muluk S; Schenk W; Burks SG; Grigorian A; Ploder B; Presch I; Pavlova BG; Hantak E
    Ann Vasc Surg; 2011 Aug; 25(6):813-22. PubMed ID: 21514114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomized study comparing fibrin sealant to manual compression for the treatment of anastomotic suture-hole bleeding in expanded polytetrafluoroethylene grafts.
    Saha SP; Muluk S; Schenk W; Dennis JW; Ploder B; Grigorian A; Presch I; Goppelt A
    J Vasc Surg; 2012 Jul; 56(1):134-41. PubMed ID: 22633423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prospective, Randomized, Phase III Study to Evaluate the Efficacy and Safety of Fibrin Sealant Grifols as an Adjunct to Hemostasis as Compared to Cellulose Sheets in Hepatic Surgery Resections.
    Bjelović M; Ayguasanosa J; Kim RD; Stojanović M; Vereczkei A; Nikolić S; Winslow E; Emre S; Xiao G; Navarro-Puerto J; Courtney K; Barrera G;
    J Gastrointest Surg; 2018 Nov; 22(11):1939-1949. PubMed ID: 29967969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrin Sealant Patch (TachoSil) vs Oxidized Regenerated Cellulose Patch (Surgicel Original) for the Secondary Treatment of Local Bleeding in Patients Undergoing Hepatic Resection: A Randomized Controlled Trial.
    Genyk Y; Kato T; Pomposelli JJ; Wright JK; Sher LS; Tetens V; Chapman WC
    J Am Coll Surg; 2016 Mar; 222(3):261-8. PubMed ID: 26776356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FINISH-3 trial: a phase 3, international, randomized, single-blind, controlled trial of topical fibrocaps in intraoperative surgical hemostasis.
    Bochicchio GV; Gupta N; Porte RJ; Renkens KL; Pattyn P; Topal B; Troisi RI; Muir W; Chetter I; Gillen DL; Zuckerman LA; Frohna PA
    J Am Coll Surg; 2015 Jan; 220(1):70-81. PubMed ID: 25458801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Hemostatic Patch That Stops Bleeding in Cardiovascular and Peripheral Vascular Procedures.
    Howk K; Fortier J; Poston R
    Ann Vasc Surg; 2016 Feb; 31():186-95. PubMed ID: 26597233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of a new fibrin sealant with standard topical hemostatic agents.
    Schwartz M; Madariaga J; Hirose R; Shaver TR; Sher L; Chari R; Colonna JO; Heaton N; Mirza D; Adams R; Rees M; Lloyd D
    Arch Surg; 2004 Nov; 139(11):1148-54. PubMed ID: 15545559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective randomized study evaluating an absorbable cyanoacrylate for use in vascular reconstructions.
    Lumsden AB; Heyman ER;
    J Vasc Surg; 2006 Nov; 44(5):1002-1009; discussion 1009. PubMed ID: 17020801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase III, randomized, controlled, superiority trial evaluating the fibrin pad versus standard of care in controlling parenchymal bleeding during elective hepatic surgery.
    Koea JB; Batiller J; Patel B; Shen J; Hammond J; Hart J; Fischer C; Garden OJ
    HPB (Oxford); 2013 Jan; 15(1):61-70. PubMed ID: 23216780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.
    Mathiasen RA; Cruz RM
    Otolaryngol Head Neck Surg; 2004 Nov; 131(5):601-5. PubMed ID: 15523433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of recombinant thrombin to bovine thrombin as a hemostatic ancillary in patients undergoing peripheral arterial bypass and arteriovenous graft procedures.
    Weaver FA; Lew W; Granke K; Yonehiro L; Delange B; Alexander WA;
    J Vasc Surg; 2008 Jun; 47(6):1266-73. PubMed ID: 18440754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of an oxidized cellulose patch hemostatic agent in thyroid surgery: a prospective, randomized, controlled study.
    Amit M; Binenbaum Y; Cohen JT; Gil Z
    J Am Coll Surg; 2013 Aug; 217(2):221-5. PubMed ID: 23870217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgicel Nu-Knit hemostat for bleeding control of fragile sternum.
    Mair H; Kaczmarek I; Oberhoffer M; Groetzner J; Daebritz S; Reichart B
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):605-6. PubMed ID: 16077453
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and hemostatic efficacy of fibrin pad in partial nephrectomy: results of an open-label phase I and a randomized, standard-of-care-controlled phase I/II study.
    Nativ O; Patel B; Shen J; Batiller J; Horn S; Hart JC
    BMC Nephrol; 2012 Nov; 13():147. PubMed ID: 23137020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the topical hemostatic efficacy and safety of TISSEEL VH S/D fibrin sealant compared with currently licensed TISSEEL VH in patients undergoing cardiac surgery: a phase 3, randomized, double-blind clinical study.
    Lowe J; Luber J; Levitsky S; Hantak E; Montgomery J; Schiestl N; Schofield N; Marra S;
    J Cardiovasc Surg (Torino); 2007 Jun; 48(3):323-31. PubMed ID: 17505437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prospective, Randomized, Multicenter Clinical Trial on the Safety and Efficacy of a Ready-to-Use Fibrin Sealant as an Adjunct to Hemostasis during Vascular Surgery.
    Chetter I; Stansby G; Sarralde JA; Riambau V; Giménez-Gaibar A; MacKenzie K; Acín F; Navarro-Puerto J;
    Ann Vasc Surg; 2017 Nov; 45():127-137. PubMed ID: 28647631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.